The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 8
  • 1
    Hawthorne, Grant
    Individual (14 offsprings)
    Officer
    2022-12-02 ~ now
    OF - Secretary → CIF 0
  • 2
    Miller, Neil Derek, Dr
    Director born in June 1970
    Individual (3 offsprings)
    Officer
    2018-04-05 ~ now
    OF - Director → CIF 0
  • 3
    Savidge, Jonathan Rex
    Company Director born in September 1973
    Individual (2 offsprings)
    Officer
    2023-04-06 ~ now
    OF - Director → CIF 0
  • 4
    Nessi, Claudio
    Investment Manager born in November 1968
    Individual (1 offspring)
    Officer
    2022-06-30 ~ now
    OF - Director → CIF 0
  • 5
    Draetta, Francesco
    Investment Manager born in November 1984
    Individual (1 offspring)
    Officer
    2022-06-30 ~ now
    OF - Director → CIF 0
  • 6
    Jackman, Katherine
    Investment Manager born in August 1981
    Individual (1 offspring)
    Officer
    2023-10-19 ~ now
    OF - Director → CIF 0
  • 7
    Roach, Arthur
    Company Director born in November 1957
    Individual (4 offsprings)
    Officer
    2019-06-27 ~ now
    OF - Director → CIF 0
  • 8
    PARKINSON'S DISEASE SOCIETY OF THE UNITED KINGDOM - now
    PARKINSON'S DISEASE SOCIETY OF THE UNITED KINGDOM LIMITED - 1985-08-22
    215, Vauxhall Bridge Road, London, England
    Active Corporate (15 parents, 4 offsprings)
    Person with significant control
    2019-06-27 ~ now
    PE - Has significant influence or controlCIF 0
Ceased 5
  • 1
    Hawthorne, Grant
    Director born in July 1972
    Individual (14 offsprings)
    Officer
    2018-04-05 ~ 2019-06-27
    OF - Director → CIF 0
    Mr Grant Hawthorne
    Born in July 1972
    Individual (14 offsprings)
    Person with significant control
    2018-04-05 ~ 2022-06-30
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Tobin, Jonathan Leslie
    Venture Capitalist born in December 1982
    Individual (6 offsprings)
    Officer
    2022-06-30 ~ 2023-10-19
    OF - Director → CIF 0
  • 3
    Dr Neil Derek Miller
    Born in June 1970
    Individual (3 offsprings)
    Person with significant control
    2018-04-05 ~ 2022-06-30
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 4
    Seabrook, Richard Nicholas, Dr
    Strategic Adviser born in March 1959
    Individual (2 offsprings)
    Officer
    2019-11-05 ~ 2022-06-30
    OF - Director → CIF 0
  • 5
    Rutter, Anthony Richard, Dr
    Director born in February 1975
    Individual (3 offsprings)
    Officer
    2018-04-05 ~ 2019-06-27
    OF - Director → CIF 0
    Dr Anthony Richard Rutter
    Born in February 1975
    Individual (3 offsprings)
    Person with significant control
    2018-04-05 ~ 2022-06-30
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

NRG THERAPEUTICS LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
102023-05-01 ~ 2024-04-30
72022-05-01 ~ 2023-04-30
Property, Plant & Equipment
7,842 GBP2024-04-30
13,045 GBP2023-04-30
Fixed Assets
7,842 GBP2024-04-30
13,045 GBP2023-04-30
Debtors
1,443,284 GBP2024-04-30
9,246,145 GBP2023-04-30
Cash at bank and in hand
5,252,323 GBP2024-04-30
3,837,804 GBP2023-04-30
Current Assets
6,695,607 GBP2024-04-30
13,083,949 GBP2023-04-30
Creditors
Current, Amounts falling due within one year
-1,794,832 GBP2024-04-30
-765,694 GBP2023-04-30
Net Current Assets/Liabilities
4,900,775 GBP2024-04-30
12,318,255 GBP2023-04-30
Total Assets Less Current Liabilities
4,908,617 GBP2024-04-30
12,331,300 GBP2023-04-30
Net Assets/Liabilities
4,908,617 GBP2024-04-30
12,331,300 GBP2023-04-30
Equity
Called up share capital
4,534 GBP2024-04-30
4,534 GBP2023-04-30
Share premium
17,614,607 GBP2024-04-30
17,614,607 GBP2023-04-30
Retained earnings (accumulated losses)
-12,710,524 GBP2024-04-30
-5,287,841 GBP2023-04-30
Equity
4,908,617 GBP2024-04-30
12,331,300 GBP2023-04-30
Property, Plant & Equipment - Gross Cost
Computers
15,608 GBP2024-04-30
15,608 GBP2023-04-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Computers
2,563 GBP2023-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
5,203 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
7,766 GBP2024-04-30
Property, Plant & Equipment
Computers
7,842 GBP2024-04-30
13,045 GBP2023-04-30
Other Debtors
Non-current
19,619 GBP2024-04-30
14,314 GBP2023-04-30
Debtors
Non-current
19,619 GBP2024-04-30
14,314 GBP2023-04-30
Other Debtors
Current
1,088,163 GBP2024-04-30
796,330 GBP2023-04-30
Called-up share capital (not paid)
Current
8,000,001 GBP2023-04-30
Prepayments/Accrued Income
Current
335,502 GBP2024-04-30
435,500 GBP2023-04-30
Debtors
Current
1,443,284 GBP2024-04-30
9,246,145 GBP2023-04-30
Trade Creditors/Trade Payables
Current
990,138 GBP2024-04-30
336,849 GBP2023-04-30
Taxation/Social Security Payable
Current
34,821 GBP2024-04-30
29,187 GBP2023-04-30
Other Creditors
Current
501,686 GBP2024-04-30
2,158 GBP2023-04-30
Accrued Liabilities/Deferred Income
Current
268,187 GBP2024-04-30
397,500 GBP2023-04-30
Creditors
Current
1,794,832 GBP2024-04-30
765,694 GBP2023-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
900,000 shares2024-04-30
900,000 shares2023-04-30
Par Value of Share
Class 1 ordinary share
0.0012023-05-01 ~ 2024-04-30
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
407,925 shares2024-04-30
407,925 shares2023-04-30
Par Value of Share
Class 2 ordinary share
0.0012023-05-01 ~ 2024-04-30
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
3,225,807 shares2024-04-30
Par Value of Share
Class 3 ordinary share
0.0012023-05-01 ~ 2024-04-30

  • NRG THERAPEUTICS LTD
    Info
    Registered number 11294505
    Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts SG1 2FX
    Private Limited Company incorporated on 2018-04-05 (7 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-04
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.